Elago, Belmar L.
HRN: 13-59-51 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
CEFTAZIDIME 1GM (VIAL)
11/14/2023
11/20/2023
IVT
1g
Q8
CAP MR
Waiting Final Action